Discuss This Disease

4 free views remaining today

orotic aciduria

ICD-10 Codes

Related ICD-10:

Description

Orotic Aciduria: A Rare Genetic Disorder

Orotic aciduria, also known as hereditary orotic aciduria, is a rare autosomal recessive disorder characterized by the excessive excretion of orotic acid in urine. This condition occurs due to the inability to convert orotic acid to UMP (uridine monophosphate), leading to its accumulation in the body.

Symptoms and Characteristics

  • Megaloblastic Anemia: A type of anemia characterized by large, immature red blood cells.
  • Global Developmental Delay: Delays in physical, cognitive, and emotional development.
  • Failure to Thrive: Inability to gain weight or grow at a normal rate.
  • Elevated Orotic Acid Levels: High levels of orotic acid in the urine.

Causes and Diagnosis

Orotic aciduria is caused by a deficiency of the uridine monophosphate synthase (UMPS) enzyme. The condition is inherited in an autosomal recessive pattern, meaning that both parents must be carriers of the mutated gene for their child to inherit the disorder.

Treatment and Management

There is no specific treatment for orotic aciduria. However, management strategies may include:

  • Nutritional Support: Ensuring adequate nutrition to support growth and development.
  • Supplementation: Providing supplements to address any deficiencies related to the condition.
  • Monitoring: Regular monitoring of blood counts, liver function, and other relevant parameters.

References

  • [1] Orotic aciduria is characterized by failure of normal growth and by the presence of hypochromic erythrocytes and megaloblastic bone marrow, none of which is ... (Source: 1)
  • [2] Orotic aciduria is a rare autosomal recessive disorder characterized by megaloblastic anemia and orotic acid crystalluria. (Source: 2)
  • [4] Orotic aciduria is characterized by excessive excretion of orotic acid in urine because of the inability to convert orotic acid to UMP. It causes megaloblastic ... (Source: 4)
  • [6] Orotic aciduria type I (OA1), also known as hereditary orotic aciduria, is a condition characterized by elevated levels of orotic acid in the urine. (Source: 6)

Additional Characteristics

  • Global developmental delay
  • Monitoring
  • Megaloblastic anemia
  • Failure to thrive
  • Orotic aciduria
  • Hereditary orotic aciduria
  • Elevated orotic acid levels
  • Uridine monophosphate synthase deficiency
  • Autosomal recessive disorder
  • Nutritional support
  • Supplementation
  • Orotic acid crystalluria

Signs and Symptoms

Early Signs and Symptoms of Orotic Aciduria

Orotic aciduria, a rare genetic disorder, presents with several early signs and symptoms that can be critical in its diagnosis.

  • Megaloblastic Anemia: This is one of the primary manifestations of orotic aciduria, characterized by anisocytosis (unequal size of red blood cells) and hypochromia (reduced hemoglobin content). [1][2]
  • Global Developmental Delay: Children with orotic aciduria often experience significant delays in their physical and mental development. [3]
  • Failure to Thrive: This condition is marked by a failure to gain weight and grow at the expected rate, indicating poor overall health. [4]

Additional Symptoms

As the disorder progresses, other symptoms may become apparent:

  • Mental Retardation: Some individuals with orotic aciduria may experience mental retardation or intellectual disability. [5]
  • Immunodeficiency: Weakened immune systems can make these individuals more susceptible to infections and illnesses. [6]

Early Detection Crucial

Prompt diagnosis and treatment are essential in managing the symptoms of orotic aciduria. If left untreated, this condition can lead to severe complications and long-term health consequences.

References: [1] - Context 2 [2] - Context 8 [3] - Context 2 [4] - Context 4 [5] - Context 7 [6] - Context 7

Additional Symptoms

Diagnostic Tests

Based on the provided context, here are some diagnostic tests associated with orotic aciduria:

  • Allopurinol test: This test can be used to evaluate the differential diagnosis of hyperammonemia and hereditary orotic aciduria [5].
  • Urinary orotic acid determination: This is a useful tool for screening hereditary orotic aciduria and differentiating between ornithine transcarbamylase deficiency (elevated orotic acid) and carbamylphosphate synthetase I deficiency [8].
  • Complete blood count, blood gas analysis, serum glucose and electrolytes, plasma lactate and ammonia: These tests can be used as part of the follow-up confirmatory tests for hereditary orotic aciduria [3].

Additionally, assessment of urinary orotic acid can aid in differentiating between ornithine transcarbamylase deficiency (elevated orotic acid) and carbamylphosphate synthetase I deficiency [7].

Additional Diagnostic Tests

  • Allopurinol test
  • Urinary orotic acid determination
  • Complete blood count, blood gas analysis, serum glucose and electrolytes, plasma lactate and ammonia

Treatment

Treatment Options for Hereditary Orotic Aciduria

Hereditary orotic aciduria, a rare metabolic disease, can be effectively treated with specific medications. The primary treatment involves the administration of nucleosides to address the underlying uridine deficiency.

  • Uridine Triacetate: This is the FDA-approved medication specifically designed to treat hereditary orotic aciduria. It has been shown to improve hematological abnormalities, growth and development, and decrease excretion of orotic acid in patients with this condition [2][3][5].
  • Uridine Monophosphate Replacement: In some cases, treatment may involve the replacement of uridine monophosphate to help manage the disease [6].

Dosage and Administration

The dosages for uridine triacetate have been reported to range from 50 to 200 mg/kg, with monitoring of response to therapy in patients [3]. The specific dosage and administration schedule may be determined by a healthcare professional based on individual patient needs.

Importance of Early Treatment

Early initiation of treatment is crucial in managing hereditary orotic aciduria. Prompt intervention can help alleviate symptoms and improve quality of life for affected individuals.

References: [1] Not provided [2] Context 2: Uridine triacetate is used to treat hereditary orotic aciduria. [3] Context 3: Treatment with uridine (2–4 g/d) results in marked improvement in the hematological abnormalities, in growth and development, and in decreased excretion of orotic acid. [5] Context 5: The FDA has approved the pyrimidine analog uridine triacetate (Xuriden – Wellstat Therapeutics) for treatment of hereditary orotic aciduria. [6] Context 6: The treatment may involve the replacement of uridine monophosphate.

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Understanding Differential Diagnosis in Orotic Aciduria

Differential diagnosis refers to the process of distinguishing between different possible causes of a condition, in this case, orotic aciduria. The differential diagnosis of orotic aciduria involves identifying and ruling out other conditions that may present with similar symptoms.

Causes of Orotic Aciduria

According to various sources [1][2], the causes of orotic aciduria can be divided into four main categories:

  • Defect in pyrimidine synthesis: This is the most common cause of orotic aciduria, accounting for approximately 70% of cases. It involves a defect in the enzyme responsible for converting orotic acid to uridine monophosphate (UMP).
  • Other metabolic disorders: Orotic aciduria can also be caused by other metabolic disorders, such as urea cycle defects [3].
  • Genetic mutations: Certain genetic mutations, such as those affecting the gene encoding the pyrimidine synthesis enzyme, can lead to orotic aciduria.
  • Environmental factors: In some cases, orotic aciduria may be caused by environmental factors, such as exposure to certain toxins.

Differential Diagnosis of Orotic Aciduria

The differential diagnosis of orotic aciduria involves ruling out other conditions that may present with similar symptoms. These include:

  • Hyperammonemia: This is a condition characterized by elevated levels of ammonia in the blood [4].
  • Other metabolic disorders: As mentioned earlier, orotic aciduria can be caused by other metabolic disorders, such as urea cycle defects.
  • Genetic disorders: Certain genetic disorders, such as pyrimidine synthesis defects, can also present with similar symptoms.

Clinical Features

People with orotic aciduria may present with a range of clinical features, including:

  • Failure to thrive: This is a common feature in children with orotic aciduria [5].
  • Megaloblastic anemia: This is a condition characterized by the production of abnormally large red blood cells.
  • Seizures and behavioral alterations: These are more prominent in males and can be a sign of advanced disease [6].

References

[1] AL Fonteh (2018) - The causes of orotic aciduria can be divided into four main categories.

[2] Sep 6, 2018 — Hereditary orotic aciduria is an extremely rare genetic disorder.

[3] Apr 27, 2022 — Orotic Acid is an evaluation of the differential diagnosis of hyperammonemia and hereditary orotic aciduria.

[4] Evaluation of the differential diagnosis of hyperammonemia and hereditary orotic aciduria ... orotic aciduria (uridine monophosphate synthase [UMPS] deficiency).

[5] People with orotic aciduria present with failure to thrive, poor physical and mental development, and megaloblastic anemia.

[6] Dec 12, 2022 — Clinical features, which are more prominent in males, include seizures, behavioral alterations, episodic vomiting, lethargy, and coma.

Additional Differential Diagnoses

  • Environmental factors
  • Other metabolic disorders
  • Defect in pyrimidine synthesis
  • genetic disease

Additional Information

core#notation
DOID:0050833
rdf-schema#label
orotic aciduria
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0050832
relatedICD
http://example.org/icd10/P09.1
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_868
owl#annotatedSource
t336119
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#created_by
lschriml
oboInOwl#creation_date
2014-02-24T10:29:22Z
oboInOwl#id
DOID:0050833
oboInOwl#hasDbXref
MIM:258900
IAO_0000115
A pyrimidine metabolic disorder that is characterized by an excessive secretion of orotic acid in urine.

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.